Notably, mitoxantrone (MIT) has demonstrated potential to stimulate cGAS-STING signaling, with studies confirming the feasibility of co-delivering MIT and NAP via nanoparticles for synergistic chemoimmunotherapy in HCC (166). Here, CGAS is linked to hepatocellular carcinoma.